Watanabe Toshifumi, Higashi Daijiro, Kaida Hiroki, Irie Hisatoshi, Hanaoka Katsuzo, Yamakado Jin, Maki Toshimitsu, Hirano Yosuke, Nagano Hideki, Watanabe Masato
Department of Surgery, Fukuoka University Chikushi Hospital, Fukuoka, Japan.
J Anus Rectum Colon. 2024 Jul 30;8(3):150-156. doi: 10.23922/jarc.2023-060. eCollection 2024.
The present study reviewed cases of Toxic megacolon (TM) treated in our department, summarized the timing and technique of surgery, and considered key points for surgical management.
This single-center retrospective study included the medical records of patients clinically diagnosed with TM who underwent surgery between 1985 and 2020. The diagnostic criteria and screening scores for sepsis, such as the systemic inflammatory response syndrome (SIRS) criteria, quick Sequential Organ Failure Assessment (qSOFA) score, and Modified Early Warning Score (MEWS), were validated. The preoperative clinical features and perioperative findings were also investigated.
There were eight male and six female patients. Nine patients (64.3%) satisfied the criteria for toxemia proposed by Narabayashi, and 10 patients (71.4%) fulfilled the SIRS criteria. A positive qSOFA score was confirmed in 1 patient (7.1%). The MEWS was high in 2 patients (14.3%). Intestinal perforation occurred in 2 patients (14.3%), and 1 of them died from disseminated intravascular coagulation. The mortality rate of TM with perforation was 50%. Eleven patients (78.6%) underwent total colectomy with end ileostomy.
TM does not have well-defined diagnostic criteria, in addition to developing sometimes as borderline or fulminant cases, and must be recognized at an early stage, taking various findings into consideration. The criteria proposed by Narabayashi and the SIRS criteria, which met in a high percentage of our cases, are recommended as indicators for determining the toxicity of TM. It is also important to consider surgery in the early stages of TM, even if clinical findings do not meet all the criteria.
本研究回顾了我院治疗的中毒性巨结肠(TM)病例,总结了手术时机和技术,并探讨了手术治疗的关键点。
这项单中心回顾性研究纳入了1985年至2020年间临床诊断为TM并接受手术治疗的患者的病历。验证了脓毒症的诊断标准和筛查评分,如全身炎症反应综合征(SIRS)标准、快速序贯器官衰竭评估(qSOFA)评分和改良早期预警评分(MEWS)。还调查了术前临床特征和围手术期发现。
男性患者8例,女性患者6例。9例患者(64.3%)符合Narabayashi提出的毒血症标准,10例患者(71.4%)符合SIRS标准。1例患者(7.1%)qSOFA评分呈阳性。2例患者(14.3%)MEWS较高。2例患者(14.3%)发生肠穿孔,其中1例死于弥散性血管内凝血。TM合并穿孔的死亡率为50%。11例患者(78.6%)接受了全结肠切除加末端回肠造口术。
TM没有明确的诊断标准,此外有时会发展为临界或暴发性病例,必须早期识别,综合考虑各种表现。Narabayashi提出的标准和SIRS标准在我们的病例中符合率较高,建议作为判断TM毒性的指标。即使临床表现未满足所有标准,在TM早期考虑手术也很重要。